ConductScience.org, home

Paper499332

Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma.

Herlyn D and 3 others. Eur J Immunol, 1979. Cited by 159 papers, by iCite.

Cite this record

ConductScience Library. Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma. Papers, record 499332. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/499332

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma.
PubMed
Journal
Eur J Immunol
PubMed
Year
1979
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
159
iCite
Relative citation ratio, by iCite
3.88
iCite
Revised in PubMed
2022-02-25
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Herlyn DD
2Herlyn MM
3Steplewski ZZ
4Koprowski HH

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, NeoplasmMajor topic
Antibody-Dependent Cell CytotoxicityMajor topic
Colonic NeoplasmsMajor topic
MelanomaMajor topic
Rectal NeoplasmsMajor topic
Animals
Cell Line
Clone Cells
Cytotoxicity, Immunologic
Humans
Mice
Mice, Nude

Source PubMed

Download CSV of topics

Cited by54

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 159 citations.

PMIDTitleJournalYearIn PapersSource
40242505Nanotherapeutic strategies exploiting biological traits of cancer stem cells.Bioact Mater2025https://conductscience.org/library/papers/40242505PubMed
38791091Regulation of the Function and Expression of EpCAM.Biomedicines2024https://conductscience.org/library/papers/38791091PubMed
38612911Informed by Cancer Stem Cells of Solid Tumors: Advances in Treatments Targeting Tumor-Promoting Factors and Pathways.Int J Mol Sci2024https://conductscience.org/library/papers/38612911PubMed
36238297Recent advances in CAR-T cells therapy for colorectal cancer.Front Immunol2022https://conductscience.org/library/papers/36238297PubMed
35891197NK Cell-Based Immunotherapy in Colorectal Cancer.Vaccines (Basel)2022https://conductscience.org/library/papers/35891197PubMed
34790117Targeting Wnt Signaling in the Tumor Immune Microenvironment to Enhancing EpCAM CAR T-Cell therapy.Front Pharmacol2021https://conductscience.org/library/papers/34790117PubMed
34209658Functional Implications of the Dynamic Regulation of EpCAM during Epithelial-to-Mesenchymal Transition.Biomolecules2021https://conductscience.org/library/papers/34209658PubMed
32486423Current View on EpCAM Structural Biology.Cells2020https://conductscience.org/library/papers/32486423PubMed
30185875EpCAM homo-oligomerization is not the basis for its role in cell-cell adhesion.Sci Rep2018https://conductscience.org/library/papers/30185875PubMed
28393933EpCAM Intracellular Domain Promotes Porcine Cell Reprogramming by Upregulation of Pluripotent Gene Expression via Beta-catenin Signaling.Sci Rep2017https://conductscience.org/library/papers/28393933PubMed
26292218Cleavage and cell adhesion properties of human epithelial cell adhesion molecule (HEPCAM).J Biol Chem2015https://conductscience.org/library/papers/26292218PubMed
26116735Antibodies: At The Nexus of Antigens and Cancer Vaccines.J Infect Dis2015https://conductscience.org/library/papers/26116735PubMed
24937249Remembrances of Hilary Koprowski from a Surgeon's Perspective.Monoclon Antib Immunodiagn Immunother2014https://conductscience.org/library/papers/24937249PubMed
24906438The overexpression of epithelial cell adhesion molecule (EpCAM) in glioma.J Neurooncol2014https://conductscience.org/library/papers/24906438PubMed
22647938EpCAM and its potential role in tumor-initiating cells.Cell Adh Migr2012https://conductscience.org/library/papers/22647938PubMed
21196254Colon cancer stem cells: implications in carcinogenesis.Front Biosci (Landmark Ed)2011https://conductscience.org/library/papers/21196254PubMed
18508155Use of antibodies and immunoconjugates for the therapy of more accessible cancers.Adv Drug Deliv Rev2008https://conductscience.org/library/papers/18508155PubMed
17622246Characterisation of the new EpCAM-specific antibody HO-3: implications for trifunctional antibody immunotherapy of cancer.Br J Cancer2007https://conductscience.org/library/papers/17622246PubMed
10965023Antibody-dependent cytotoxicity mediated by chimeric monoclonal antibody Nd2 and experimental immunotherapy for pancreatic cancer.Jpn J Cancer Res2000https://conductscience.org/library/papers/10965023PubMed
10852962Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors.Proc Natl Acad Sci U S A2000https://conductscience.org/library/papers/10852962PubMed

See all 54 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/499332

GET https://conductscience.org/api/papers/v1/499332/cited_by?page=2